Raman Mitra, MD
Clinical Cardiac Electrophysiology · South Bend, INNPI 1528062221
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (34.6%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Biosense Webster, Inc. at 44.5% of the total. Reporting peaked in 2019 at $28,140 and has fallen 93.7% since, to $1,763 in 2025.
Across 184 payments — averaging $271.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$22K
- Johnson & Johnson$15K
- Medtronic$5K
- Abbott$3K
- Philips North America LLC$2K
- Boston Scientific$1K
- plus $1K from 17 others
Across 1 payment — averaging $9505.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$10K
What the payments were for
- Consulting fees$17,27835%
- Speaking & faculty fees$11,70023%
- Travel & lodging$13,03826%
- Food & beverage$7,92916%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 45 | $22,240 |
| Johnson & Johnson | 20 | $15,309 |
| Medtronic(2 entities) | 47 | $4,990 |
| Abbott | 22 | $2,720 |
| Philips North America LLC | 1 | $2,000 |
| Boston Scientific | 15 | $1,361 |
| Cvrx, Inc. | 2 | $244 |
| Impulse Dynamics (USA) Inc. | 2 | $206 |
| Siemens Medical Solutions USA, Inc. | 3 | $202 |
| Stereotaxis Inc | 4 | $181 |
| Novartis | 7 | $175 |
| Atricure, Inc. | 2 | $66 |
| Cordis US CORP. | 2 | $50 |
| Covidien LP | 1 | $46 |
| Amgen | 2 | $34 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $30 |
| Edwards Lifesciences | 1 | $20 |
| Cardiva Medical, Inc. | 1 | $17 |
| GE HealthCare | 1 | $15 |
| Davol Inc. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Boehringer Ingelheim | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3 System$16,994
- Carto Smarttouch$16,302
- XARELTO$15,141
- Carto CFAE$11,019
- CartoSound$11,019
- Carto 3$3,069
- IGT D Peripheral$2,000
- AVEIR$1,923
- Watchman$409
- Micra$372
- COBALT DR MRI SURESCAN$282
- SYMPLICITY G3$220
- Barostim Neo System$178
- SelectSecure$174
- OPTIMIZER SMART SYSTEM$153
- WATCHMAN FLX$150
- CardioMEMS HF System$146
- QDOT MICRO Catheter$136
- ARCTIC FRONT ADVANCE$132
- AURORA EV-ICD MRI SURESCAN$130
How this compares
$49,959 in reported general payments places this provider in the 80th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
See all clinical cardiac electrophysiology providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 114 | $127,422 |
| MultaqDronedarone Hcl | 24 | $39,943 |
| XareltoRivaroxaban | 35 | $37,318 |
| EntrestoSacubitril/Valsartan | 11 | $15,051 |
| Metoprolol Succinate | 116 | $2,120 |
| Amiodarone Hcl | 33 | $1,241 |
| Flecainide Acetate | 31 | $649 |
| Eplerenone | 15 | $495 |
| Losartan Potassium | 31 | $321 |
| SotalolSotalol Hcl | 20 | $282 |
| Amlodipine Besylate | 35 | $214 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 12 | $134 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sanofi-aventis U.S. LLCMultaq | $13 | $39,94324 claims |
| Johnson & JohnsonXarelto | $15,309 | $37,31835 claims |
| NovartisEntresto | $175 | $15,05111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 72 clinical cardiac electrophysiology providers in Indiana.
Other clinical cardiac electrophysiology in South Bend
- Deepak GabaSouth Bend$12K
- Yosef KahnSouth Bend$7K
- Eric PrystowskyIndianapolis$1.1M
- Chad BonhommeWestfield$925K
- Kevin TrulockIndianapolis$402K
- Sharath VipparthyIndianapolis$114K
- Jasen GilgeIndianapolis$93K
- Vincent KeatingIndianapolis$80K
- Christopher ReedIndianapolis$80K
- Marcelle StuckyIndianapolis$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.